Smith Lindsay R, Faragó Fanni, Blue Thomas, Witte James C, Gordon Michael S, Taxman Faye S
Department of Criminology, Law and Society, George Mason University, Fairfax, Virginia, USA.
Department of Sociology & Anthropology, George Mason University, Fairfax, Virginia, USA.
Subst Use Misuse. 2023;58(13):1780-1788. doi: 10.1080/10826084.2023.2247076. Epub 2023 Aug 18.
Overdose deaths in the United States (U.S.) surpassed 100,000 in 2021. Problem-solving courts (PSCs), which originally began as drug courts, divert people with nonviolent felonies and underlying social issues (e.g. opioid use disorders (OUDs)) from the carceral system to a community-based treatment court program. PSCs are operated by a collaborative court staff team including a judge that supervises PSC clients, local court coordinators that manage PSC operations, among other staff. Based on staff recommendations, medications for opioid use disorders (MOUDs) can be integrated into court clients' treatment plans. MOUDs are an evidence-based treatment option. However, MOUDs remain widely underutilized within criminal justice settings partially due to negative perceptions of MOUDs held by staff. PSCs are an understudied justice setting where MOUD usage would be beneficial. This study sought to understand how court coordinators' perceptions and attitudes about MOUDs influenced their uptake and utilization in PSCs. A nationally representative survey of 849 local and 42 state PSC coordinators in the U.S. was conducted to understand how coordinators' perceptions influenced MOUD utilization. Generally, court coordinators hold positive views of MOUDs, especially naltrexone. While state and local coordinators' views do not differ greatly, their stronger attitudes align with different aspects of and issues in PSCs such as medication diversion (i.e. misuse). This study has implications for PSCs and their staff, treatment providers, and other community supervision staff (e.g. probation/parole officers, court staff) who can promote and encourage the use of MOUDs by clients.
2021年,美国的过量用药死亡人数超过了10万。问题解决法庭最初是作为毒品法庭设立的,它将犯有非暴力重罪且存在潜在社会问题(如阿片类药物使用障碍)的人从监禁系统转移到基于社区的治疗法庭项目。问题解决法庭由一个协作的法庭工作人员团队运作,包括一名监督问题解决法庭客户的法官、管理问题解决法庭运作的当地法庭协调员以及其他工作人员。根据工作人员的建议,阿片类药物使用障碍药物(MOUDs)可以纳入法庭客户的治疗计划。MOUDs是一种基于证据的治疗选择。然而,MOUDs在刑事司法环境中仍未得到充分利用,部分原因是工作人员对MOUDs存在负面看法。问题解决法庭是一个研究较少的司法环境,在其中使用MOUDs会有好处。本研究旨在了解法庭协调员对MOUDs的看法和态度如何影响它们在问题解决法庭中的采用和使用。对美国849名地方和42名州问题解决法庭协调员进行了一项具有全国代表性的调查,以了解协调员的看法如何影响MOUDs的使用。总体而言,法庭协调员对MOUDs,尤其是纳曲酮持积极看法。虽然州和地方协调员的观点差异不大,但他们更强烈的态度与问题解决法庭的不同方面和问题(如药物转移,即滥用)相一致。这项研究对问题解决法庭及其工作人员、治疗提供者以及其他社区监督工作人员(如缓刑/假释官员、法庭工作人员)具有启示意义,他们可以促进并鼓励客户使用MOUDs。